Risk Management · 2025
In this section4 topics
Risk Management Policy & Plan
Policy & Plan Description
Aesthetic Connect Public Company Limited, acknowledges that risk management is an integral part of good corporate governance, which is a crucial foundation for achieving the company's objectives. Identifying and managing risks will support better decision-making, help uncover opportunities, and mitigate the impacts of significant events that may affect shareholders. Risk is defined as the possibility of an event occurring that could impact the company's objectives, and it can be measured by its impact and the likelihood of occurrence.
Objectives
Aesthetic Connect Public Company Limited has defined the objectives of the Risk Management Policy in alignment with the company's vision, mission, and strategy as follows:
1.To ensure that Aesthetic Connect Public Company Limited has a systematic and effective risk management process in place, in accordance with international risk management frameworks and good corporate governance principles.
2.To ensure that Aesthetic Connect Co., Ltd. (Public) has a risk management team, with all personnel actively involved in risk management, including systematic monitoring, evaluation, and reporting, and to reduce concerns among staff and management regarding risks that could affect operational efficiency.
3.To ensure that Aesthetic Connect Co., Ltd. (Public) has measures for monitoring, preventing, and managing risks to reduce the likelihood and severity of obstacles and issues that may lead to losses or failures, which could hinder the achievement of objectives. The company will have contingency plans in place for dealing with severe risks or losses when they occur.
4.To ensure that Aesthetic Connect Co., Ltd. (Public) can analyze the root causes of risk events, resolve them to an acceptable level through effective risk management, reduce the impact of risks using alert systems or management systems, and establish appropriate emergency or recovery plans.
Scope
This Risk Management Policy covers the management of risks for Aesthetic Connect Co., Ltd. (Public), encompassing all types of risks in healthcare and beauty services. These risks include: Strategic Risk Operational Risk, which is further divided into: Clinical Risk Non-Clinical Risk Financial Risk and Reporting Risk Compliance Risk Human Capital Risk Reputation Risk Technology Risk Environmental & Hazard Risk Fraud and Sentinel Events (which include Adverse Events, No-Harm Events, and Near Miss Events) Additionally, this policy applies to all operations within the company, including to the management and all employees.
Enterprise Risk Management Policy
Aesthetic Connect Public Company Limited , recognizes and values the importance of enterprise risk management to drive sustainable growth, expand business operations with stability, maintain a strong financial position, and generate appropriate returns for shareholders. Additionally, risk management aligns with the principles of Good Corporate Governance and the check-and-balance system, which are essential in the ever-changing competitive business environment influenced by both internal and external factors. These factors may impact the company’s ability to achieve its objectives and key missions. To ensure effective risk management, the company has adopted the COSO Enterprise Risk Management framework as outlined by The Committee of Sponsoring Organizations of the Treadway Commission. This approach aims to enhance confidence among shareholders and stakeholders, ensuring the company's continuous operations while supporting the achievement of corporate objectives and value creation. The company’s risk management guidelines and policies were approved during the Board of Directors Meeting No. 1/2568 (Public Company) on February 21, 2025, as follows:
1) The company shall implement a systematic, organization-wide risk management approach aligned with international best practices and Good Corporate Governance principles. The framework must consider healthcare service quality standards and academic principles to create value for the organization. The Board of Directors shall define the risk management policy, and the Risk Management Committee shall develop risk management strategies. All employees at every level shall be responsible for recognizing and prioritizing risk management in accordance with the company's risk management framework.
2) The company shall establish risk prevention and mitigation measures to manage operational risks and unforeseen events. Risk identification and control processes shall be conducted systematically to ensure that risks remain at acceptable levels at the organizational, departmental, unit, and activity levels. If a particular risk entails excessive mitigation costs that outweigh the benefits or involves external factors beyond the company's control, approval must be obtained from the Board of Directors.
3) The Risk Management Working Group is responsible for collecting information, reviewing performance results, and monitoring compliance with risk management policies. The Risk Manager is responsible for supervising and ensuring that each department operates in accordance with the Company’s risk management policies in all areas.
Department heads are responsible for monitoring, supervising, and reporting risks, as well as serving as members of sub-committees related to risks within their respective departments. The Company also promotes a culture of risk awareness by encouraging the reporting of potential risks, risk incidents, and undesirable events, whereby employees at all levels are able to report such matters.
4) All risks that impact the company’s ability to achieve its objectives must be addressed through the following steps:
-Timely identification of risks.
-Assessment of risk occurrence probability and impact.
-Implementation of risk management measures based on the company’s risk management criteria while considering associated costs and benefits.
-Continuous monitoring to ensure appropriate risk management.
5) High and critical risks that may impact the company’s business plans and strategies must be reported to the Executive Committee, Audit Committee, and Board of Directors.
Responsibilities
1.The Board of Directors has overall responsibility for overseeing risk management within the company.
2.The Audit Committee supports the Board of Directors in risk management oversight by reviewing and ensuring that the risk management system is appropriate and effective.
3.The Executive Committee is responsible for considering and reviewing the company's risk management and internal control systems.
4.The Chairman of the Executive Committee is responsible for implementing this policy and ensuring its continuous compliance through the Risk Management Working Group, which consists of executives from key company departments, with the Chief Executive Officer serving as the Chairman.
5.The Risk Management Working Group is responsible for ensuring that significant business risks are consistently identified and assessed, as well as for establishing effective risk management measures. Its responsibilities include:
-Developing risk management policies, strategies, and guidelines for review and approval by the Board of Directors.
-Reviewing the company's risk assessment and management approaches as evaluated by the respective risk owners and providing recommendations for improvement.
-Overseeing the effectiveness of the company's risk management processes through ongoing monitoring and review.
-Reporting high and critical risk levels to the Chairman of the Executive Committee, the Executive Committee, the Audit Committee, and the Board of Directors.
-Regularly reviewing this policy.
6.The Internal Audit Department is responsible for reviewing the effectiveness of internal controls through annual internal audits, which assess key business processes based on risk factors, and for monitoring the resolution of identified deficiencies.
7.All executives and employees are responsible for identifying, analyzing, assessing, and prioritizing risks within their areas of responsibility, as well as implementing appropriate risk management measures.
Risk Management Approach
The company has established a risk management process to serve as a guideline for all departments in implementing effective risk management practices. This process is based on the principles of the COSO-ERM 2017 international standard. The specific procedures for each step of the risk management process are outlined in the "Corporate Risk Management Manual"
Risk Factors — Overview
Risk Factors — Introduction
In conducting its business, the company inevitably faces various risks, similar to other businesses. However, the identified risk factors do not represent all the risks that the company may encounter. There may be additional risk factors that the company is currently unaware of or considers insignificant at present but could have a significant impact in the future on its business, revenue, profits, assets, liquidity, funding sources, financial performance forecasts, business operation policies, changes in laws related to the company’s business, government policies, and other relevant factors. These forward-looking statements are not guarantees of future events, and actual outcomes may differ significantly from the company’s expectations.
Risks to the Company's Business Operations
Risk Register
| Risk Name | Risk Characteristics | Consequences | Management Measures | Related Risk Factors |
|---|---|---|---|---|
| Risks from intense competition in the industry | The aesthetic services business is highly competitive, both from existing service providers and the increasing number of new entrants. Competition also intensifies in terms of marketing strategies and pricing to effectively reach target customer segments. Nevertheless, the aesthetic industry continues to demonstrate strong growth, as cosmetic procedures have become more widely accepted in Thai society. Consumers increasingly place importance on enhancing their appearance for both social and professional benefits, leading to rising demand for aesthetic surgery and skincare services. As a result, more new players have entered the market, intensifying competition and potentially impacting the Company’s operating performance. However, Aesthetic Connect Public Company Limited recognizes such risks and places strong emphasis on service quality and standards as its key competitive strategy. The Company is led by Asst.Prof.Dr.Choladhis Sinrachtanant, who is widely recognized for his expertise and long-standing reputation in aesthetic surgery. He is also an innovator of several surgical techniques, such as short-incision double eyelid surgery and autologous fat grafting for rhinoplasty. Asst.Prof.Dr.Choladhis Sinrachtanant plays a key role in transferring knowledge and techniques to the medical team at Teeraporn Hospital, providing guidance during procedures and reviewing post-operative outcomes to ensure that services meet established standards. This ensures that the Company consistently delivers high-quality procedures and results that meet patient expectations. In addition, the Company provides personalized consultation services, where medical advisors assess each client’s readiness and facial condition and recommend appropriate procedures tailored to individual needs. Currently,Cdr. Suwannee Jirayangyuen, the Company’s founder and major shareholder, serves as a principal medical advisor in this process. These practices ensure that the Company delivers high-quality services throughout the entire customer journey—from initial consultation to post-procedure care—resulting in strong customer satisfaction. This enables the Company to retain its existing customer base and benefit from word-of-mouth referrals, thereby reducing the impact of price competition within the industry. The Company’s strong operational performance growth over recent years further demonstrates its ability to effectively navigate increasing competition in the industry. | The aesthetic surgery and beauty services industry is highly competitive, with competition arising from both existing operators with established customer bases and new entrants continuously entering the market. This has led to intensified competition in marketing, branding, and pricing strategies in order to effectively reach and respond to target customer segments. Nevertheless, the industry continues to demonstrate steady growth, as Thai society has become more open to aesthetic procedures and beauty treatments. At the same time, consumers increasingly place importance on their physical appearance, both for social purposes and career opportunities. This has resulted in a continuous increase in demand for aesthetic surgery and skincare services. However, such growth in demand has attracted a significant number of new entrants into the market, further intensifying industry competition, which may have a material impact on the Company’s operating performance in the long term. | The Company places the highest importance on the quality and standards of its services as its core priority. It is led by Asst.Prof.Dr.Choladhis Sinrachtanant, a highly skilled and widely recognized specialist in aesthetic procedures with a long-standing reputation in the cosmetic surgery industry. He plays a key role in advancing the Company’s medical knowledge and innovation. Asst.Prof.Dr.Choladhis Sinrachtanant has been instrumental in developing and introducing new techniques in various procedures, such as short-incision double eyelid surgery and autologous fat grafting for rhinoplasty. He also continuously transfers his knowledge and expertise to the medical team at Teeraporn Hospital, provides guidance during procedures, and conducts post-treatment evaluations to ensure that all services meet the Company’s established standards. In addition, the Company has appointed medical advisors to assess and provide recommendations to every patient prior to treatment. This includes evaluating each individual’s readiness and unique characteristics, as well as recommending the most appropriate treatment techniques to ensure outcomes that align with the patient’s facial structure and expectations, thereby enhancing satisfaction and confidence in the results. Currently, Cdr. Suwannee Jirayangyuen, the Company’s founder and major shareholder, serves as the principal medical advisor in this role. With a service approach that emphasizes quality at every stage from consultation through post-treatment follow-up the Company has consistently achieved high levels of customer satisfaction. This enables the Company to retain its existing customer base while expanding new customers through word-of-mouth referrals, thereby reducing pricing pressures within the industry. The Company’s continued strong growth in operating performance over recent years further reflects its capability to adapt and compete effectively in a highly competitive industry. | 1714 · Description: Competition risk · Info category: STRATEGIC_RISK |
| Risk of shortage of doctors or healthcare professionals | The provision of aesthetic surgery services requires highly qualified physicians and medical personnel with specialized expertise and extensive experience. However, the current supply of medical professionals remains insufficient to meet market demand, particularly as demand from both domestic and international patients continues to grow steadily. At the same time, the expansion of operators within the industry has significantly increased the demand for medical personnel. Such professionals require a considerable period of time to develop the necessary knowledge, specialized skills, and experience. Accordingly, if the Company is unable to recruit, develop, or retain a sufficient number of qualified and experienced medical personnel in a timely manner, it may face risks associated with workforce shortages. This could adversely affect service quality, the Company’s capacity to accommodate patients, and its operating performance in the long term. | Currently, the production of doctors and medical personnel is insufficient to meet the growing demand from both domestic and international clients seeking cosmetic surgery. The increase in the number of industry players has intensified the demand for medical professionals, who require considerable time to develop their skills and expertise. If the company is unable to recruit or develop a team of specialized doctors and medical staff in a timely manner, there may be risks associated with a shortage of medical personnel, which could impact the company's operations. | Historically, the Company has not experienced any shortage of physicians or medical personnel. Nevertheless, the Company recognizes the importance of its medical professionals and continuously promotes their development and capability enhancement. This includes strengthening physicians’ competencies to perform a wide range of surgical procedures, encouraging the exchange of surgical techniques, and providing opportunities for knowledge sharing and case discussions among medical teams, as well as ongoing training programs to continuously build expertise among physicians and medical personnel. In addition, the Company fosters strong organizational values that promote unity and collaboration among personnel, while cultivating a positive working environment to enhance employee motivation. The Company also maintains fair and competitive compensation policies. Furthermore, the reputation of Teeraporn Hospital serves as an additional factor in attracting highly qualified physicians and medical professionals to join the organization. Accordingly, the Company is confident that these approaches will effectively mitigate the risk of shortages of physicians and medical personnel. | 739 · Description: Shortage or reliance on skilled workers · Info category: OPERATIONAL_RISK |
| Risks from changes in consumer behavior | Risk from Changes in Consumer Behavior arises from rapidly and continuously evolving consumer preferences and demands, particularly in the aesthetic surgery and beauty industry, which is highly influenced by social trends, technological advancements, digital media, and changing beauty standards over time. Such changes lead to increasingly diverse and evolving expectations in terms of services, treatment techniques, and desired outcomes. If the Company is unable to adapt to these trends in a timely manner, its services or products may no longer align with market demand, potentially resulting in a loss of competitiveness in both attracting new customers and retaining existing ones. In addition, shifts in consumer behavior may affect the effectiveness of the Company’s marketing strategies, brand communication, and service development, which could, in turn, adversely impact the Company’s revenue and operating performance in the long term. | If the Company is unable to keep pace with or adapt to such trends in a timely manner, it may lose business opportunities in both attracting new customers and retaining its existing customer base, which could adversely affect the Company’s revenue and operating performance in the long term. | The Company places strong emphasis on continuously studying and analyzing consumer behavior. It has established dedicated teams to monitor trends, market preferences, technologies, and innovations in aesthetic procedures, as well as to conduct customer satisfaction surveys. The insights obtained are analyzed and utilized in formulating marketing strategies and enhancing service delivery to effectively and timely meet customer needs. The Company believes that such an approach will strengthen its competitiveness and support sustainable long-term business growth. | 729 · Description: Behavior or needs of customers / consumers · Info category: STRATEGIC_RISK |
| Risk of dependence on key personnel | As the company or Teeraporn Hospital is led by Assistant Professor Dr. Choladhis Sinrachtanant, who is both an instructor to all the doctors and a key executive with extensive experience, knowledge, and expertise, as well as being well-known and respected in the industry, the company has historically used his name alongside Teeraporn Hospital, such as "Teeraporn Hospital by Dr. Choladhis," to create brand awareness and make the business easily recognizable to customers. However, this reliance on the prominent executive also presents a risk, as it creates a dependency on the key executive for the company's recognition and reputation. | Customers recognize the Teeraporn Hospital brand because of Assistant Professor Dr. Choladhis Sinrachtanant. However, this also creates a risk for the company, as it becomes dependent on a key executive for its recognition and reputation. | The Company recognizes the potential risks and has therefore implemented the following risk mitigation measures:
| 738 · Description: Reliance on employees in key positions · Info category: OPERATIONAL_RISK |
| Risk of litigation for providing services | Risk of Lawsuits Due to Services Provided ,As the company operates in the cosmetic surgery business, it places significant emphasis on providing high-quality treatments and ensuring customer satisfaction. Each customer has different expectations regarding the outcomes, and the results of procedures depend on individual skin conditions. If the outcome of a procedure does not meet the customer’s expectations and fails to satisfy them, it may lead to public criticism on social media, complaints to relevant authorities, or even legal actions. This could impact the company’s reputation and performance. However, the company prioritizes customer satisfaction at all stages, from selecting qualified physicians who have the ability to perform procedures to continuously developing internal doctors to ensure their expertise in meeting customers' needs. The company has established a risk management team to assess and monitor customer satisfaction levels, which allows the company to evaluate operational effectiveness and serve as a preventive measure against potential lawsuits. Additionally, the company implements precautionary measures to systematically and effectively reduce possible risks. Moreover, the company offers a one-year post-surgery result guarantee. Before any procedure, customers are required to sign a consent form acknowledging that they understand the possibility of unforeseen medical circumstances or unsatisfactory results, which might require additional treatments or corrective surgeries. The customer is informed that, while medical procedures allow additional charges, the company guarantees that no extra charges will be applied within one year, and the company will cover all related costs. To prevent any unforeseen issues or lawsuits that may impact the physicians, the company requires all doctors to purchase Medical Malpractice Insurance to reduce the risk of costs arising from potential lawsuits. As of December 31, 2025, the company has not faced any lawsuits or claims for damages related to healthcare services that would impact the company. | As the company operates in the cosmetic surgery business, it places a strong emphasis on providing high-quality treatments that meet customer satisfaction. Each customer has different expectations regarding the outcomes, and the results of procedures depend on individual skin conditions. If the outcomes of the procedures do not meet the customers' expectations and fail to satisfy them, it may lead to criticism on social media, complaints to relevant authorities, and even legal actions. This could impact the company's reputation and overall performance. | The company places great importance on customer satisfaction, starting from the selection process of doctors to ensure that they have the necessary skills for performing procedures. The company also continuously develops its in-house doctors to enhance their surgical expertise and ensure they are capable of delivering high-quality results that meet customer needs. Additionally, the company has established a risk management task force to assess and monitor customer satisfaction and improve operational efficiency, which also serves as a preventive measure to minimize the risk of lawsuits. Furthermore, the company offers a one-year post-surgery result guarantee. Before any procedure, customers are required to sign a consent form, which states: "I am aware that all medical procedures, including surgeries, may have unforeseen circumstances, and the results may not always be as expected. If corrective surgery or treatment is required, although medical practice allows for additional charges, I have received confirmation from the surgeon that no additional charges will be made within one year." The company is responsible for all related expenses. To prevent any unforeseen events from leading to legal action that could affect the doctor, the company requires all its doctors to take out Medical Malpractice Insurance to reduce the risk of costs arising from lawsuits. As of December 31, 2025, the company has not faced any lawsuits for damages related to healthcare services that would affect the company's operations. | 729 · Description: Behavior or needs of customers / consumers · Info category: STRATEGIC_RISK · 1723 · Description: Legal risk · Info category: COMPLIANCE_RISK · 736 · Description: Damage to company image and reputation · Info category: STRATEGIC_RISK |
| Regulatory and Legal Compliance Risk | The Company operates a specialized hospital business under the supervision and regulation of the Ministry of Public Health and other relevant government authorities. As a result, the Company is required to comply with various laws, regulations, rules, and notifications governing its business operations and ensuring public safety. These include notifications and regulations issued by the Medical Council, notifications of the Ministry of Public Health, ministerial regulations on the characteristics and service standards of healthcare facilities, the Medical Profession Act, the Consumer Protection Act, the Sanatorium Act, and the Food and Drug Act, among others. In addition, the Company is required to obtain and maintain licenses for operating and managing healthcare facilities in accordance with applicable laws. Any changes in the interpretation of existing laws, regulations, rules, or notifications, as well as the introduction of new laws or regulations with increasingly stringent requirements, may have an impact on the Company’s operations. Nevertheless, the Company recognizes the importance of regulatory compliance and places strong emphasis on adhering to all relevant laws, regulations, and requirements. The Company has established policies requiring its personnel to closely monitor regulatory developments, as well as to participate in training and seminars to stay informed of updates from relevant government authorities. This ensures that the Company remains compliant with all applicable legal and regulatory requirements. | If the Company fails to fully comply with applicable laws, regulations, and requirements governing healthcare facility operations, it may be subject to penalties imposed by regulatory authorities, such as warnings, fines, suspension, or revocation of its operating licenses. This could directly affect the continuity of the Company’s business operations. In addition, non-compliance may adversely impact service standards, customer confidence, and the Company’s reputation and corporate image. This could lead to a loss of business opportunities and negatively affect the Company’s revenue and operating performance in the long term. | The Company recognizes the importance of compliance with applicable laws, regulations, rules, and requirements. Accordingly, the Company places strong emphasis on adhering to all relevant regulatory and legal frameworks. The Company has established policies requiring its personnel to continuously monitor and review regulatory developments, as well as to participate in training programs and seminars in order to stay informed of updates and information from relevant government authorities concerning healthcare operations. This ensures that the Company is able to comply accurately and effectively with all applicable laws, regulations, and requirements. | 756 · Description: Change in laws and regulations · Info category: COMPLIANCE_RISK · 757 · Description: Laws and regulations is not favorable for doing business · Info category: COMPLIANCE_RISK · 730 · Description: Government policy · Info category: STRATEGIC_RISK |
Risks to Securities Holders' Investment
Risk Register
| Risk Name | Risk Characteristics | Consequences | Management Measures | Related Risk Factors |
|---|---|---|---|---|
| Risk of holding more than 50% of shares by major shareholders | Risk of a Major Shareholder Holding More Than 50% After the IPO After the initial public offering (IPO),Suwannee Jirayangyuen and family namely San Fun Holding CO., LTD, and Mr. Thanachak Sinrachatanant and Mr. Choladhorn Sinrachatanant and Mr. Chakchalat Sinrachatanant, collectively hold more than 50% of the company's shares. This significant shareholding proportion grants these major shareholders control over the company's management and decision-making. They have the power to influence key shareholder meeting resolutions, including the appointment of directors, amendments to the company's regulations, and approvals requiring a majority vote, except for matters requiring at least three-fourths of the votes from attending and eligible shareholders, as stipulated by law or company regulations. As a result, minority shareholders may not be able to gather sufficient votes to scrutinize or counterbalance proposals put forth by the major shareholders. However, the company has structured its board of directors to include independent directors making up at least one-third of the total board members. The chairman of the board is an independent director, and independent directors also serve on the audit committee to oversee the company's operations and ensure that all actions are conducted in the company's best interests. Additionally, the company has established clear and transparent scopes of authority, responsibilities, and delegations of power for directors and executives. Measures have been implemented to regulate related-party transactions involving directors, major shareholders, controlling persons, and parties with conflicts of interest. These individuals are not permitted to vote on the approval of such transactions, ensuring transparency and the company's best interests in all business operations. | Minority shareholders may not be able to gather sufficient votes to scrutinize or counterbalance proposals put forth by the major shareholders. | The company's board structure consists of independent directors making up at least one-third of the total board members. The chairman of the board is an independent director, and independent directors also serve on the audit committee to oversee the company's operations and ensure that all actions are conducted in the company's best interests. Additionally, the company has established clear and transparent scopes of operations, duties, and responsibilities, as well as the delegation of authority to directors and executives. Measures have been implemented to regulate related-party transactions involving directors, major shareholders, controlling persons, and individuals with conflicts of interest. These individuals are not permitted to vote on the approval of such transactions, ensuring transparency and the company’s best interests in all business operations. | 2969 · Description: Risk of the company having a majority shareholder holding > 50% of shares · Info category: HOLDER_RISK |

